Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Astrapharm is a leading Ukrainian pharmaceutical company founded in 2003, specializing in the development and manufacture of high-quality generic medicines and dietary supplements. The company operates a modern, GMP-certified manufacturing facility in Vyshneve, Ukraine, producing over 100 different drug products across therapeutic areas such as cardiology, gastroenterology, and neurology. Astrapharm has established a significant presence in the Georgian market, where it provides a wide range of affordable essential medicines including antihistamines, proton pump inhibitors, and antifungals. With a production capacity of over 1 billion tablets per year, the company is committed to expanding its international footprint and entering the top 10 pharmaceutical manufacturers in Ukraine by 2025. Its operations are supported by an in-house physico-chemical analysis laboratory ensuring rigorous quality control at all stages of production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Astrapharm Georgia.